longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

XTALPI

02228

6.8750.72% ( -0.050 )
Delay Closed: Sep 16, 16:08:46
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -121.80, within the reasonable range, cheaper than 41% of the time in the past 1 years, and the industry ranks 15/15, the industry Median 14.65.

-121.8xP/E
HK$6.88Stock price
HK$-0.06Earnings per share
-121.8xP/E
Stock priceHK$6.88Earnings per shareHK$-0.06

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-183.85x
Typical range
-226.12x–249.71x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 14.65x
014284256

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 14.65x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
01548HKGENSCRIPT BIO
-14.87x95.10%HK$74.25B
02228HKXTALPI
-121.80x130.90%HK$29.58B
03696HKINSILICO
-12.56x100.52%HK$29.31B
02576HKTAIMEI TECH
-35.63x--HK$2.67B
08225HKC HEALTH GP
-4.88x--HK$79.63M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.